Heliospectra AB (OMX:HELIO)(OTC:HLSPY) announced this morning that the company has received an order for its intelligent lighting products valued at $93,500 (790 000 SEK) from THCultivation.
THCultivation is building a facility in Oregon and they plan to initiate an extensive breeding program and cultivate eight different strains using a double tier vertical rack system to optimize space.
THCultivation's Director of Cultivation, Bruce Caruso had this to say about why they went with Heliospectra:
"We want to focus on the vegetation stage with the goal of taking clones to one gallon plants in four weeks. The ability to establish strong, healthy plants from day one and dial in the light strategies by strain with granular control over the far red is critical. Heliospectra is the most advanced and flexible sole source lighting solution on the market for our indoor growing environment."
In late trading in Sweden, shares of Heliospectra AB are up roughly 3%. The company's OTC Markets symbol hasn't traded yet today. Year-to-date, Heliospectra shares have had a rough go of it and are down nearly 50%.
Learn more about Heliospectra AB by checking out the company's marijuana stock profile in The Daily Marijuana Observer's cannabis stock database.
If the business of lighting interests you, be sure to check out Tokyo-listed, Iwasaki Electric Co., LTD. (JPX:6924). Iwasaki Electric is also one of the few marijuana related stocks that pays a dividend.
Be sure to subscribe to one or more of The Daily Marijuana Observer's free e-mail newsletters so you never miss an important cannabis industry update. Also, don't forget to connect with The Daily Marijuana Observer on Facebook, Twitter, and Instagram.
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.